2024 Q1 Form 10-K Financial Statement

#000178217024000037 Filed on February 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $269.1M $264.8M $944.3M
YoY Change 32.01% 38.59% 44.48%
Cost Of Revenue $89.88M $89.12M $329.1M
YoY Change 21.35% 24.01% 27.16%
Gross Profit $179.2M $175.6M $615.2M
YoY Change 38.09% 47.39% 55.85%
Gross Profit Margin 66.6% 66.34% 65.15%
Selling, General & Admin $132.3M $143.9M $496.3M
YoY Change 25.45% 47.92% 34.02%
% of Gross Profit 73.82% 81.94% 80.68%
Research & Development $63.21M $59.24M $219.9M
YoY Change 28.01% 38.14% 58.55%
% of Gross Profit 35.26% 33.73% 35.75%
Depreciation & Amortization $3.678M $3.488M $13.12M
YoY Change 21.43% 88.13% 95.09%
% of Gross Profit 2.05% 1.99% 2.13%
Operating Expenses $63.21M $206.6M $219.9M
YoY Change 28.01% 45.49% 58.55%
Operating Profit -$19.95M -$31.00M -$114.2M
YoY Change -28.91% 35.56% -5.65%
Interest Expense $769.0K $1.461M $2.352M
YoY Change 97.69% -24.96% 80.65%
% of Operating Profit
Other Income/Expense, Net -$1.586M -$64.00K -$2.838M
YoY Change 4.96% -105.86% -154.44%
Pretax Income -$20.08M -$29.60M -$111.9M
YoY Change -28.13% 49.3% -0.92%
Income Tax $998.0K $5.417M $5.902M
% Of Pretax Income
Net Earnings -$21.08M -$35.02M -$117.8M
YoY Change -25.55% 80.57% 3.35%
Net Earnings / Revenue -7.83% -13.23% -12.48%
Basic Earnings Per Share -$0.11 -$0.65
Diluted Earnings Per Share -$0.11 -$0.19 -$0.65
COMMON SHARES
Basic Shares Outstanding 188.5M shares 185.2M shares 180.8M shares
Diluted Shares Outstanding 189.8M shares 180.8M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $488.0M $519.6M $519.6M
YoY Change 7.88% 13.27% 13.27%
Cash & Equivalents $286.0M $323.7M $519.6M
Short-Term Investments
Other Short-Term Assets $1.160M $1.317M $33.14M
YoY Change -96.3% -93.19% 71.49%
Inventory
Prepaid Expenses $22.73M $11.12M
Receivables
Other Receivables $4.025M $0.00
Total Short-Term Assets $972.0M $932.1M $932.1M
YoY Change 60.15% 39.24% 39.24%
LONG-TERM ASSETS
Property, Plant & Equipment $19.34M $16.01M $25.54M
YoY Change 52.75% 38.66% 26.28%
Goodwill $54.94M $54.94M
YoY Change -0.09%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.173M $7.071M $7.071M
YoY Change 4.52% 13.79% 12.01%
Total Long-Term Assets $107.2M $104.2M $104.2M
YoY Change -0.98% 292.66% 292.66%
TOTAL ASSETS
Total Short-Term Assets $972.0M $932.1M $932.1M
Total Long-Term Assets $107.2M $104.2M $104.2M
Total Assets $1.079B $1.036B $1.036B
YoY Change 50.9% 48.9% 48.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.28M $35.05M $35.05M
YoY Change 322.07% 415.91% 415.91%
Accrued Expenses $155.1M $145.8M $151.8M
YoY Change 95.12% 66.15% 147.91%
Deferred Revenue
YoY Change
Short-Term Debt $2.445M $2.481M $2.481M
YoY Change -1.81%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $367.8M $366.8M $366.8M
YoY Change 86.28% 75.4% 75.4%
LONG-TERM LIABILITIES
Long-Term Debt $150.0M $130.0M $130.0M
YoY Change
Other Long-Term Liabilities $6.653M $5.653M $10.13M
YoY Change -51.2% 438.38% 50.65%
Total Long-Term Liabilities $156.7M $135.7M $140.1M
YoY Change 1049.16% 12819.33% 1984.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $367.8M $366.8M $366.8M
Total Long-Term Liabilities $156.7M $135.7M $140.1M
Total Liabilities $529.8M $507.0M $507.0M
YoY Change 141.1% 134.85% 134.85%
SHAREHOLDERS EQUITY
Retained Earnings -$512.4M -$491.3M
YoY Change 27.53% 31.55%
Common Stock $19.00K $19.00K
YoY Change 5.56% 11.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $549.4M $529.3M $529.3M
YoY Change
Total Liabilities & Shareholders Equity $1.079B $1.036B $1.036B
YoY Change 50.9% 48.9% 48.9%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$21.08M -$35.02M -$117.8M
YoY Change -25.55% 80.57% 3.35%
Depreciation, Depletion And Amortization $3.678M $3.488M $13.12M
YoY Change 21.43% 88.13% 95.09%
Cash From Operating Activities -$56.81M -$34.47M -$53.59M
YoY Change -13219.63% -55.44% -49.03%
INVESTING ACTIVITIES
Capital Expenditures $945.0K $2.584M $2.857M
YoY Change 9.38% 6.78% -22.34%
Acquisitions $0.00 $40.93M
YoY Change -100.0% 16405.24%
Other Investing Activities $0.00 -$3.000K -$40.93M
YoY Change -100.0% -102.36% 16405.24%
Cash From Investing Activities -$4.314M -$2.587M -$50.04M
YoY Change -89.99% 12.82% 584.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $17.07M
YoY Change 4344.79%
Cash From Financing Activities $26.12M 136.2M $126.7M
YoY Change -291.55% 4626.48% 1043.98%
NET CHANGE
Cash From Operating Activities -$56.81M -34.47M -$53.59M
Cash From Investing Activities -$4.314M -2.587M -$50.04M
Cash From Financing Activities $26.12M 136.2M $126.7M
Net Change In Cash -$36.10M 99.11M $24.30M
YoY Change -35.63% -229.12% -123.68%
FREE CASH FLOW
Cash From Operating Activities -$56.81M -$34.47M -$53.59M
Capital Expenditures $945.0K $2.584M $2.857M
Free Cash Flow -$57.75M -$37.05M -$56.45M
YoY Change 13299.77% -53.55% -48.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2838000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5213000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-112976000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37713000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1043000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
581000 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001782170
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
Remitly Global, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2301143
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1111 Third Avenue,
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2100
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle,
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
CY2023 dei City Area Code
CityAreaCode
888
CY2023 dei Local Phone Number
LocalPhoneNumber
736-4859
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2023 dei Trading Symbol
TradingSymbol
RELY
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
2491700000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
188505173 shares
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Seattle, Washington
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
323710000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300635000 usd
CY2023Q4 rely Disbursement Prefunding Receivables Current
DisbursementPrefundingReceivablesCurrent
195848000 usd
CY2022Q4 rely Disbursement Prefunding Receivables Current
DisbursementPrefundingReceivablesCurrent
158055000 usd
CY2023Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
379417000 usd
CY2022Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
191402000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33143000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19327000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
932118000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
669419000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16010000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11546000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9525000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8675000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
54940000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16642000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7071000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6313000 usd
CY2023Q4 us-gaap Assets
Assets
1036306000 usd
CY2022Q4 us-gaap Assets
Assets
695953000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
35051000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6794000 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
177473000 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
111075000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2481000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
145802000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87752000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6032000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3521000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
366839000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
209142000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4477000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5674000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
130000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5653000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1050000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
506969000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
215866000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188435952 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
188435952 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173250865 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
173250865 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1020286000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
854276000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
335000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-743000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-491303000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-373463000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
529337000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480087000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1036306000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
695953000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
944285000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
653560000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458605000 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
234417000 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
170970000 usd
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
120906000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219939000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
138719000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64093000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
179372000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
131250000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
70941000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6724000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5256000 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
498327000 usd
CY2023 us-gaap Interest Expense
InterestExpense
2352000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-111938000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5902000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1043000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-117840000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-114019000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-38756000 usd
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180818399 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180818399 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167774123 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167774123 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60728748 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60728748 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-117840000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-114019000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-38756000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1078000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-996000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-338000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-116762000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115015000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39094000 usd
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480087000 usd
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6132000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14667000 usd
CY2023 rely Stock Issued During Period Value Donations
StockIssuedDuringPeriodValueDonations
4600000 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6635000 usd
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6702000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
140099000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1078000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-117840000 usd
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
529337000 usd
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
480328000 usd
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3516000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12271000 usd
CY2022 rely Stock Issued During Period Value Donations
StockIssuedDuringPeriodValueDonations
1972000 usd
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
99000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97114000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-996000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-114019000 usd
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480087000 usd
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
127082605 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
387707000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-211329000 usd
CY2021 rely Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
328026 shares
CY2021 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
2980000 usd
CY2021 rely Adjustments To Additional Paid In Capital Non Recourse Promissory Note
AdjustmentsToAdditionalPaidInCapitalNonRecoursePromissoryNote
3060000 usd
CY2021 rely Temporary Equity Shares Redeemed Upon Conversion Shares
TemporaryEquitySharesRedeemedUponConversionShares
127410631 shares
CY2021 rely Temporary Equity Shares Redeemed Upon Conversion Amount
TemporaryEquitySharesRedeemedUponConversionAmount
390687000 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
390687000 usd
CY2021 rely Stock Issued During Period Value Donations
StockIssuedDuringPeriodValueDonations
6933000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7421000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
169000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17290000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-338000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-38756000 usd
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
480328000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-117840000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-114019000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-38756000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13118000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6724000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5256000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
136967000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
95293000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
17016000 usd
CY2023 us-gaap Noncash Contribution Expense
NoncashContributionExpense
4600000 usd
CY2022 us-gaap Noncash Contribution Expense
NoncashContributionExpense
1972000 usd
CY2021 us-gaap Noncash Contribution Expense
NoncashContributionExpense
6933000 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-713000 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-356000 usd
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-452000 usd
CY2023 rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
31778000 usd
CY2022 rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
38428000 usd
CY2021 rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
18069000 usd
CY2023 rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
183422000 usd
CY2022 rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
126942000 usd
CY2021 rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
17282000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13035000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4598000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12559000 usd
CY2023 rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-5186000 usd
CY2022 rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-3763000 usd
CY2021 rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-2780000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
27559000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5535000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3035000 usd
CY2023 rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
61718000 usd
CY2022 rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
42979000 usd
CY2021 rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
16097000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
47357000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
22782000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
26071000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4733000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4073000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3295000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53590000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-108656000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18391000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2857000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3679000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1956000 usd
CY2023 us-gaap Payments For Software
PaymentsForSoftware
6247000 usd
CY2022 us-gaap Payments For Software
PaymentsForSoftware
3382000 usd
CY2021 us-gaap Payments For Software
PaymentsForSoftware
2578000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
40933000 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
248000 usd
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50037000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7309000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4534000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14288000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11554000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8345000 usd
CY2023 rely Proceeds From Issuance Of Common Stock Espp
ProceedsFromIssuanceOfCommonStockESPP
6132000 usd
CY2022 rely Proceeds From Issuance Of Common Stock Espp
ProceedsFromIssuanceOfCommonStockESPP
3516000 usd
CY2021 rely Proceeds From Issuance Of Common Stock Espp
ProceedsFromIssuanceOfCommonStockESPP
0 usd
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
764000000 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2023 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
634000000 usd
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
80000000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6702000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
99000 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17068000 usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
384000 usd
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
305191000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3060000 usd
CY2023 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
2980000 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1373000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
126650000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14587000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
238203000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1272000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1201000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-40000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24295000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-102579000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
215238000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300734000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403313000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188075000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
325029000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300734000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403313000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
323710000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300635000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
403262000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
774000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
545000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
99000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
51000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
325029000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300734000 usd
CY2023Q4 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
170 country
CY2021Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
305200000 usd
CY2021Q3 rely Sale Of Stock Stock Issuance Costs
SaleOfStockStockIssuanceCosts
20800000 usd
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Shares
TemporaryEquitySharesRedeemedUponConversionShares
127410631 shares
CY2021Q3 rely Temporary Equity Convertible Conversion Ratio
TemporaryEquityConvertibleConversionRatio
1
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These consolidated financial statements and notes have been prepared consistently, with the exception of the reclassification of certain prior year amounts within the Company’s Consolidated Statements of Cash Flows. Beginning in the year ended December 31, 2023, the Company changed the presentation of shares purchased under the ESPP to reflect an operating cash outflow for compensation paid to employees and a financing cash inflow for cash paid by employees in exchange for shares. Previously such activity was treated and disclosed as noncash activity in the amount of $3.5 million for the year ended December 31, 2022. There were no shares purchased under the ESPP for the year ended December 31, 2021. The Company has conformed the prior period statement of cash flows to the current period presentation to enhance transparency and provide comparability.</span></div>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed within the consolidated financial statements and accompanying notes. These estimates and assumptions include, but are not limited to, revenue recognition including the treatment of sales incentive programs, reserves for transaction losses, stock-based compensation expense, the carrying value of operating lease right-of-use assets, the recoverability of deferred tax assets, capitalization of software development costs, goodwill, and the recoverability of intangible assets. The key assumptions applied for value of the intangible assets include revenue growth rates for a hypothetical market participant, selected discount rates, as well as migration curves for developed technology. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. Actual results could differ from these estimates and assumptions, and these differences could be material to the consolidated financial statements.</span></div>
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2021 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, disbursement prefunding, restricted cash, and customer funds receivable. The Company maintains cash and cash equivalents and restricted cash balances that may exceed the insured limits by the Federal Deposit Insurance Corporation. In addition, the Company funds its international operations using accounts with institutions in the major countries where its subsidiaries operate. The Company also prefunds amounts which are held by its disbursement partners, which are typically located in India, Mexico, and the Philippines. The Company has not experienced any significant losses on its deposits of cash and cash equivalents, disbursement prefunding, restricted cash, or customer funds receivable in the years ended December 31, 2023, 2022, and 2021.</span></div>
CY2023 us-gaap Advertising Expense
AdvertisingExpense
181300000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
139300000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
102900000 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
CY2023 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
3339000 usd
CY2022 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
2350000 usd
CY2021 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
1139000 usd
CY2023 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
1784000 usd
CY2022 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
794000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1108000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1212000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1105000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1124000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1108000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1212000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
806000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
632000 usd
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
349000 usd
CY2023 rely Revenue From Contract With Customer Sales Incentive
RevenueFromContractWithCustomerSalesIncentive
51558000 usd
CY2022 rely Revenue From Contract With Customer Sales Incentive
RevenueFromContractWithCustomerSalesIncentive
42434000 usd
CY2021 rely Revenue From Contract With Customer Sales Incentive
RevenueFromContractWithCustomerSalesIncentive
30149000 usd
CY2021 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
187000 usd
CY2023Q4 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized After Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
4031000 usd
CY2022Q4 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized After Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
2475000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
944285000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
653560000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458605000 usd
CY2023Q4 rely Payment Card Receivable Current
PaymentCardReceivableCurrent
15599000 usd
CY2022Q4 rely Payment Card Receivable Current
PaymentCardReceivableCurrent
5558000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11122000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10256000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2813000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
970000 usd
CY2023Q4 rely Employee Loan Receivable Current
EmployeeLoanReceivableCurrent
1518000 usd
CY2022Q4 rely Employee Loan Receivable Current
EmployeeLoanReceivableCurrent
2048000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
774000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1317000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
495000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33143000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19327000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42440000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30063000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26430000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18517000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16010000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11546000 usd
CY2023 us-gaap Depreciation
Depreciation
8300000 usd
CY2022 us-gaap Depreciation
Depreciation
6700000 usd
CY2021 us-gaap Depreciation
Depreciation
5300000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
25535000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
20221000 usd
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1100000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13000000 usd
CY2023 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2100000 usd
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3800000 usd
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1100000 usd
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
13400000 usd
CY2023 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-42600000 usd
CY2023 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21500000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4858000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16642000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4858000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4858000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4525000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2401000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16642000 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1200000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1300000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
49400000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
22300000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-117840000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-114019000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-38756000 usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180818399 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180818399 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167774123 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167774123 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60728748 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60728748 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35394333 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40836038 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28075129 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 rely Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2023 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2023 us-gaap Noncash Contribution Expense
NoncashContributionExpense
4600000 usd
CY2022 us-gaap Noncash Contribution Expense
NoncashContributionExpense
2000000 usd
CY2021 us-gaap Noncash Contribution Expense
NoncashContributionExpense
6900000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
256250 shares
CY2023 rely Stock Issued During Period Shares Warrants
StockIssuedDuringPeriodSharesWarrants
254014 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Shares
TemporaryEquitySharesRedeemedUponConversionShares
127410631 shares
CY2021Q3 rely Temporary Equity Convertible Conversion Ratio
TemporaryEquityConvertibleConversionRatio
1
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Amount
TemporaryEquitySharesRedeemedUponConversionAmount
390700000 usd
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
50000000 shares
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15988268 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.11
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M14D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
119467000 usd
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4530975 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.02
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
69472000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
655897 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.96
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10801396 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.46
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M13D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
161603000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8427373 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.17
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y5M4D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
136938000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10765053 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.48
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y10M17D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
160880000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.78
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.22
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9406000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
11650000 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7311000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
69472000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
43975000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
72208000 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
1369000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
136967000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
95293000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17016000 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
1400000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
1369000 usd
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
1291000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
78000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-74776000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-116272000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-46241000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-37162000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3296000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
8528000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-111938000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-112976000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37713000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
376000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
9000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
257000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
6365000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2449000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1650000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6741000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2458000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1907000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-839000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1415000 usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-864000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-839000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1415000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-864000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5902000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1043000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1043000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0871
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0406
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.1137
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.5969
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2408
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.6651
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.1670
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0092
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.3108
CY2023 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
-0.0203
CY2021 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0
CY2023 rely Effective Income Tax Rate Reconciliation Business Acquisition Percent
EffectiveIncomeTaxRateReconciliationBusinessAcquisitionPercent
-0.0657
CY2022 rely Effective Income Tax Rate Reconciliation Business Acquisition Percent
EffectiveIncomeTaxRateReconciliationBusinessAcquisitionPercent
0
CY2021 rely Effective Income Tax Rate Reconciliation Business Acquisition Percent
EffectiveIncomeTaxRateReconciliationBusinessAcquisitionPercent
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.1498
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0040
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0079
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0029
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0527
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0092
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0277
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2900000 usd
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
2900000 usd
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 usd
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
174863000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101446000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74244000 usd
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 usd
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
58901000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
58798000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
4326000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
2270000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15623000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
13508000 usd
CY2023Q4 rely Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
1041000 usd
CY2022Q4 rely Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
1156000 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
69279000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
28605000 usd
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
10846000 usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
17341000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2748000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2442000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
180105000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
106779000 usd
CY2023Q4 rely Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
1321000 usd
CY2022Q4 rely Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
311000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
756000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1076000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1720000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2077000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3107000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
174863000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101446000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3165000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2226000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
73400000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
27200000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
25100000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101446000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74244000 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49159000 usd
CY2023 rely Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Net Income
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToNetIncome
67030000 usd
CY2022 rely Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Net Income
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToNetIncome
27202000 usd
CY2021 rely Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Net Income
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToNetIncome
25085000 usd
CY2023 rely Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Other Accounts
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToOtherAccounts
6387000 usd
CY2022 rely Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Other Accounts
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToOtherAccounts
0 usd
CY2021 rely Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Other Accounts
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToOtherAccounts
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
11438000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
4140000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15578000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15600000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4200000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4200000 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0 usd
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
18453000 usd
CY2023Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
17977000 usd
CY2023Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
7500000 usd
CY2023Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
0 usd
CY2023Q4 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
0 usd
CY2023Q4 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
0 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
43930000 usd
CY2023Q4 rely Trade Settlement Liability
TradeSettlementLiability
58950000 usd
CY2022Q4 rely Trade Settlement Liability
TradeSettlementLiability
26266000 usd
CY2023Q4 rely Accrued Transaction Expense
AccruedTransactionExpense
18500000 usd
CY2022Q4 rely Accrued Transaction Expense
AccruedTransactionExpense
15878000 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
13633000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
11394000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12990000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10251000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4026000 usd
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
9259000 usd
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
8288000 usd
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
3359000 usd
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
3762000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15295000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16212000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
145802000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87752000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
6409000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
4732000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
3824000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
5415000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
4472000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
3538000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6465000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2673000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1359000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
745000 usd
CY2023Q4 rely Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11242000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
733000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10509000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1653000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
906000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
934000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5305000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2282000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
756000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5954000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7441000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2532000 usd
CY2023 rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
377000 usd
CY2022 rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
716000 usd
CY2021 rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
482000 usd
CY2023 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3132000 usd
CY2022 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1821000 usd
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 usd
CY2023 us-gaap Stock Issued1
StockIssued1
6635000 usd
CY2022 us-gaap Stock Issued1
StockIssued1
0 usd
CY2021 us-gaap Stock Issued1
StockIssued1
0 usd
CY2023 rely Stock Issued Subject To Service Based Vesting Conditions
StockIssuedSubjectToServiceBasedVestingConditions
581000 usd
CY2022 rely Stock Issued Subject To Service Based Vesting Conditions
StockIssuedSubjectToServiceBasedVestingConditions
0 usd
CY2021 rely Stock Issued Subject To Service Based Vesting Conditions
StockIssuedSubjectToServiceBasedVestingConditions
0 usd
CY2023 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
11899000 usd
CY2022 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0 usd
CY2021 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0 usd
CY2023 rely Financing And Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
FinancingAndStockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
2401000 usd
CY2022 rely Financing And Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
FinancingAndStockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 usd
CY2021 rely Financing And Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
FinancingAndStockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 usd
CY2023 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 usd
CY2022 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 usd
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
390687000 usd
CY2023 rely Ipo And Debt Issuance Costs Incurred But Not Yet Paid
IPOAndDebtIssuanceCostsIncurredButNotYetPaid
0 usd
CY2022 rely Ipo And Debt Issuance Costs Incurred But Not Yet Paid
IPOAndDebtIssuanceCostsIncurredButNotYetPaid
0 usd
CY2021 rely Ipo And Debt Issuance Costs Incurred But Not Yet Paid
IPOAndDebtIssuanceCostsIncurredButNotYetPaid
2287000 usd
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001782170-24-000037-index-headers.html Edgar Link pending
0001782170-24-000037-index.html Edgar Link pending
0001782170-24-000037.txt Edgar Link pending
0001782170-24-000037-xbrl.zip Edgar Link pending
a103-2021equityincentive.htm Edgar Link pending
a103-2021equityincentive001.jpg Edgar Link pending
a103-2021equityincentive002.jpg Edgar Link pending
a103-2021equityincentive003.jpg Edgar Link pending
a103-2021equityincentive004.jpg Edgar Link pending
a103-2021equityincentive005.jpg Edgar Link pending
a103-2021equityincentive006.jpg Edgar Link pending
a103-2021equityincentive007.jpg Edgar Link pending
a103-2021equityincentive008.jpg Edgar Link pending
a103-2021equityincentive009.jpg Edgar Link pending
a103-2021equityincentive010.jpg Edgar Link pending
a103-2021equityincentive011.jpg Edgar Link pending
a103-2021equityincentive012.jpg Edgar Link pending
a103-2021equityincentive013.jpg Edgar Link pending
a103-2021equityincentive014.jpg Edgar Link pending
a103-2021equityincentive015.jpg Edgar Link pending
a103-2021equityincentive016.jpg Edgar Link pending
a103-2021equityincentive017.jpg Edgar Link pending
a103-2021equityincentive018.jpg Edgar Link pending
a103-2021equityincentive019.jpg Edgar Link pending
a103-2021equityincentive020.jpg Edgar Link pending
a103-2021equityincentive021.jpg Edgar Link pending
a103-2021equityincentive022.jpg Edgar Link pending
a103-2021equityincentive023.jpg Edgar Link pending
a103-2021equityincentive024.jpg Edgar Link pending
a103-2021equityincentive025.jpg Edgar Link pending
a103-2021equityincentive026.jpg Edgar Link pending
a103-2021equityincentive027.jpg Edgar Link pending
a103-2021equityincentive028.jpg Edgar Link pending
a103-2021equityincentive029.jpg Edgar Link pending
a103-2021equityincentive030.jpg Edgar Link pending
a103-2021equityincentive031.jpg Edgar Link pending
a103-2021equityincentive032.jpg Edgar Link pending
a103-2021equityincentive033.jpg Edgar Link pending
a103-2021equityincentive034.jpg Edgar Link pending
a103-2021equityincentive035.jpg Edgar Link pending
a103-2021equityincentive036.jpg Edgar Link pending
a103-2021equityincentive037.jpg Edgar Link pending
a103-2021equityincentive038.jpg Edgar Link pending
a103-2021equityincentive039.jpg Edgar Link pending
a103-2021equityincentive040.jpg Edgar Link pending
a103-2021equityincentive041.jpg Edgar Link pending
a103-2021equityincentive042.jpg Edgar Link pending
a103-2021equityincentive043.jpg Edgar Link pending
a103-2021equityincentive044.jpg Edgar Link pending
a103-2021equityincentive045.jpg Edgar Link pending
a103-2021equityincentive046.jpg Edgar Link pending
a103-2021equityincentive047.jpg Edgar Link pending
a103-2021equityincentive048.jpg Edgar Link pending
a103-2021equityincentive049.jpg Edgar Link pending
a103-2021equityincentive050.jpg Edgar Link pending
a103-2021equityincentive051.jpg Edgar Link pending
a103-2021equityincentive052.jpg Edgar Link pending
a103-2021equityincentive053.jpg Edgar Link pending
a103-2021equityincentive054.jpg Edgar Link pending
a103-2021equityincentive055.jpg Edgar Link pending
a103-2021equityincentive056.jpg Edgar Link pending
a103-2021equityincentive057.jpg Edgar Link pending
a103-2021equityincentive058.jpg Edgar Link pending
a103-2021equityincentive059.jpg Edgar Link pending
a103-2021equityincentive060.jpg Edgar Link pending
a103-2021equityincentive061.jpg Edgar Link pending
a103-2021equityincentive062.jpg Edgar Link pending
a103-2021equityincentive063.jpg Edgar Link pending
a103-2021equityincentive064.jpg Edgar Link pending
a103-2021equityincentive065.jpg Edgar Link pending
a103-2021equityincentive066.jpg Edgar Link pending
a103-2021equityincentive067.jpg Edgar Link pending
a103-2021equityincentive068.jpg Edgar Link pending
a103-2021equityincentive069.jpg Edgar Link pending
a103-2021equityincentive070.jpg Edgar Link pending
a103-2021equityincentive071.jpg Edgar Link pending
a103-2021equityincentive072.jpg Edgar Link pending
a103-2021equityincentive073.jpg Edgar Link pending
a103-2021equityincentive074.jpg Edgar Link pending
a104-remitlyx2021employe.htm Edgar Link pending
a104-remitlyx2021employe001.jpg Edgar Link pending
a104-remitlyx2021employe002.jpg Edgar Link pending
a104-remitlyx2021employe003.jpg Edgar Link pending
a104-remitlyx2021employe004.jpg Edgar Link pending
a104-remitlyx2021employe005.jpg Edgar Link pending
a104-remitlyx2021employe006.jpg Edgar Link pending
a104-remitlyx2021employe007.jpg Edgar Link pending
a104-remitlyx2021employe008.jpg Edgar Link pending
a104-remitlyx2021employe009.jpg Edgar Link pending
a104-remitlyx2021employe010.jpg Edgar Link pending
a104-remitlyx2021employe011.jpg Edgar Link pending
a104-remitlyx2021employe012.jpg Edgar Link pending
a104-remitlyx2021employe013.jpg Edgar Link pending
a104-remitlyx2021employe014.jpg Edgar Link pending
a104-remitlyx2021employe015.jpg Edgar Link pending
a104-remitlyx2021employe016.jpg Edgar Link pending
a104-remitlyx2021employe017.jpg Edgar Link pending
a104-remitlyx2021employe018.jpg Edgar Link pending
a104-remitlyx2021employe019.jpg Edgar Link pending
a104-remitlyx2021employe020.jpg Edgar Link pending
a104-remitlyx2021employe021.jpg Edgar Link pending
a104-remitlyx2021employe022.jpg Edgar Link pending
a104-remitlyx2021employe023.jpg Edgar Link pending
a104-remitlyx2021employe024.jpg Edgar Link pending
a104-remitlyx2021employe025.jpg Edgar Link pending
a104-remitlyx2021employe026.jpg Edgar Link pending
a104-remitlyx2021employe027.jpg Edgar Link pending
a104-remitlyx2021employe028.jpg Edgar Link pending
a104-remitlyx2021employe029.jpg Edgar Link pending
a104-remitlyx2021employe030.jpg Edgar Link pending
a104-remitlyx2021employe031.jpg Edgar Link pending
a104-remitlyx2021employe032.jpg Edgar Link pending
a104-remitlyx2021employe033.jpg Edgar Link pending
a104-remitlyx2021employe034.jpg Edgar Link pending
a104-remitlyx2021employe035.jpg Edgar Link pending
a104-remitlyx2021employe036.jpg Edgar Link pending
a104-remitlyx2021employe037.jpg Edgar Link pending
a104-remitlyx2021employe038.jpg Edgar Link pending
a104-remitlyx2021employe039.jpg Edgar Link pending
a104-remitlyx2021employe040.jpg Edgar Link pending
a104-remitlyx2021employe041.jpg Edgar Link pending
a104-remitlyx2021employe042.jpg Edgar Link pending
a105-changeincontrolands.htm Edgar Link pending
a105-changeincontrolands001.jpg Edgar Link pending
a105-changeincontrolands002.jpg Edgar Link pending
a105-changeincontrolands003.jpg Edgar Link pending
a105-changeincontrolands004.jpg Edgar Link pending
a105-changeincontrolands005.jpg Edgar Link pending
a105-changeincontrolands006.jpg Edgar Link pending
a105-changeincontrolands007.jpg Edgar Link pending
a105-changeincontrolands008.jpg Edgar Link pending
a105-changeincontrolands009.jpg Edgar Link pending
a105-changeincontrolands010.jpg Edgar Link pending
a105-changeincontrolands011.jpg Edgar Link pending
a105-changeincontrolands012.jpg Edgar Link pending
a105-changeincontrolands013.jpg Edgar Link pending
a105-changeincontrolands014.jpg Edgar Link pending
a105-changeincontrolands015.jpg Edgar Link pending
a105-changeincontrolands016.jpg Edgar Link pending
a971-incentivecompclawback.htm Edgar Link pending
exhibit43-relydescriptiono.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
rely-20231231.htm Edgar Link pending
rely-20231231.xsd Edgar Link pending
rely-20231231_g1.jpg Edgar Link pending
rely-20231231_g2.jpg Edgar Link pending
rely-20231231_g3.jpg Edgar Link pending
rely4q23-exhibit21110konly.htm Edgar Link pending
rely4q23-exhibit23110konly.htm Edgar Link pending
rely4q23-exhibit3111.htm Edgar Link pending
rely4q23-exhibit3121.htm Edgar Link pending
rely4q23-exhibit3211.htm Edgar Link pending
rely4q23-exhibit3221.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
rely-20231231_def.xml Edgar Link unprocessable
rely-20231231_lab.xml Edgar Link unprocessable
rely-20231231_pre.xml Edgar Link unprocessable
rely-20231231_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
rely-20231231_cal.xml Edgar Link unprocessable